Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus
about
Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with TatCo-infections and Pathogenesis of KSHV-Associated MalignanciesAntagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45.Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2.Herpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat.The intracellular virus-containing compartments in primary human macrophages are largely inaccessible to antibodies and small molecules.Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts.Viruses and human cancer: from detection to causality.Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.GB virus type C E2 protein inhibits human immunodeficiency virus type 1 Gag assembly by downregulating human ADP-ribosylation factor 1.Extreme genetic fragility of the HIV-1 capsid.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.In vivo activation of toll-like receptor-9 induces an age-dependent abortive lytic cycle reactivation of murine gammaherpesvirus-68.Evolutionary and Functional Analysis of Old World Primate TRIM5 Reveals the Ancient Emergence of Primate Lentiviruses and Convergent Evolution Targeting a Conserved Capsid InterfaceIntracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.Signaling cascades triggered by bacterial metabolic end products during reactivation of Kaposi's sarcoma-associated herpesvirus.Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latencyGB virus type C E2 protein inhibits human immunodeficiency virus type 1 assembly through interference with HIV-1 gag plasma membrane targetingToll-like receptor signaling controls reactivation of KSHV from latencyMultiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.Characterization of entry mechanisms of human herpesvirus 8 by using an Rta-dependent reporter cell line.Characterization of a myristoylated, monomeric HIV Gag protein.HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB SignalingSignaling through Toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo.
P2860
Q24800209-696B0641-8923-428F-8DD6-6E113FB012E7Q26766493-44D85671-2622-42BC-9691-526CA0EB09D4Q33582093-224570F3-C6B1-43D1-A998-37F904BC40F0Q33743857-E1913C76-7A61-404C-AB4D-557609767D78Q34162920-7C287574-D503-4EFC-BDF5-63F971B3AAC7Q34261545-EE01504D-EDD8-4DE0-B427-9EBF26090C5AQ34466295-6CDA78C9-89D0-476E-802E-0838A56444EEQ34567612-591F185A-FD61-4FBB-9CA3-7E4E164E0790Q34615002-08388F43-7B7D-4685-9922-3D2B6A457A29Q34648229-237E69FE-14DC-4E8F-AA38-471822429982Q34674878-6846C4A8-0197-47B5-88C7-338C73E39383Q34789351-E0C4B461-F8FA-47CF-A4D8-967E0CFBAEC7Q35026060-DF6C0D6C-AF18-4FFC-AC1B-781FF4C45579Q35102006-2597BD88-70AD-41F5-BB74-7BFC60A88519Q35751229-09BA20B2-623A-4E9C-9F43-EEA18779104FQ35784760-1BE20D03-7EEA-4D75-8C1B-0BED2B74D74BQ35857793-A62631E4-47BD-40C2-B203-76DE20065525Q36538689-0B7DE0A7-7036-45DC-ABC4-44F3AD8B17B7Q36641639-1AB4E5FD-54B3-4B13-80A2-E26380583151Q37261693-E235DD31-F2BB-40FE-BB16-5861EB1E374CQ39244695-820EBF35-94DD-4235-BB38-6E27F24EAC21Q39284842-CE1677ED-E7A1-4045-A8A3-01F779F124F6Q39601922-7207A566-C2B5-4ADD-9057-DCC3E5920B0AQ39776511-865C2C15-4FC4-4076-87F6-0ED14DFA183FQ39873195-B24A0210-2994-4BC2-BF75-0366FD937405Q40605490-A31B5523-346F-4E79-9AA6-666D82AA2F09Q43203738-C666B46A-72BF-4A3D-BB0C-81DD6F70B4C2
P2860
Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human immunodeficiency virus r ...... sarcoma-associated herpesvirus
@ast
Human immunodeficiency virus r ...... sarcoma-associated herpesvirus
@en
type
label
Human immunodeficiency virus r ...... sarcoma-associated herpesvirus
@ast
Human immunodeficiency virus r ...... sarcoma-associated herpesvirus
@en
prefLabel
Human immunodeficiency virus r ...... sarcoma-associated herpesvirus
@ast
Human immunodeficiency virus r ...... sarcoma-associated herpesvirus
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus r ...... sarcoma-associated herpesvirus
@en
P2093
P J Browning
P Spearman
V Varthakavi
P2860
P304
10329-10338
P577
1999-12-01T00:00:00Z